OPT opthea.com: מדד נזילות מהירה

The current market quotes for Opthea Limited (OPT) visualized below reflect the dynamics of a company whose risks are tied to the results of the final OPT-302 tests and massive capital expenditures. Meanwhile, the separate_ratio_quick is 1.58. Future revenues rely on insurance company demand for innovative treatments against blindness caused by retinal degeneration, while molecule production is outsourced to external contract manufacturing organizations.

Quick liquidity assesses the ability of Opthea Limited (OPT) to meet short-term obligations using only cash and accounts receivable, excluding inventory. For Opthea Limited, this reserve is critical when financing international clinical trials for AMD drugs. The trend of the quick ratio reflects the actual turnover rate of liquid assets. A stable level of this metric confirms the financial resilience of capital amid regulatory risks.